Sutherland Everett Rand has filed 7 insider transactions across 2 companies since June 2023.
Most recent transaction: a sale of 2093 shares of Upstream Bio, Inc. ($UPB) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Upstream Bio, Inc. | $UPB | Sutherland Everett Rand | Chief Executive Officer | S | Common Stock | 2093 | $9.29 | 72,907.0000 | 54,038,591 | 2.79% | 0.00% |
| Jan. 2, 2026 | Upstream Bio, Inc. | $UPB | Sutherland Everett Rand | Chief Executive Officer | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 54,038,591 | 9999.99% | 0.14% |
| Jan. 2, 2026 | Upstream Bio, Inc. | $UPB | Sutherland Everett Rand | Chief Executive Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 54,038,591 | 9999.99% | 0.42% |
| June 30, 2025 | Krystal Biotech, Inc. | $KRYS | Sutherland Everett Rand | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 29,740,000 | 9999.99% | 0.02% |
| Feb. 6, 2025 | Upstream Bio, Inc. | $UPB | Sutherland Everett Rand | Chief Executive Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2024 | Krystal Biotech, Inc. | $KRYS | Sutherland Everett Rand | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 27,752,000 | 9999.99% | 0.02% |
| June 30, 2023 | Krystal Biotech, Inc. | $KRYS | Sutherland Everett Rand | Director | A | Stock Option (Right to Buy) | 6800 | $0.00 | 6,800.0000 | 25,492,000 | 9999.99% | 0.03% |